Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s ...
Pfizer not only beat expectations last quarter, but also boosted its guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback